Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19. | Front Cell Infect Microbiol | 2022 | 35782122 | PubTator, text mining | PubMed |
| Latest Trends in Lateral Flow Immunoassay (LFIA) Detection Labels and Conjugation Process. | Front Bioeng Biotechnol | 2022 | 35774059 | PubTator, text mining | PubMed |
| Crystal structure of Trypanosoma cruzi heme peroxidase and characterization of its substrate specificity and compound I intermediate. | J Biol Chem | 2022 | 35772495 | PubTator, text mining | PubMed |
| The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases. | Appl Microbiol Biotechnol | 2022 | 35763069 | PubTator, text mining | PubMed |
| l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma. | J Biochem Mol Toxicol | 2022 | 35757978 | PubTator, text mining | PubMed |
| Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. | Signal Transduct Target Ther | 2022 | 35752619 | PubTator, text mining | PubMed |
| Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. | Cell | 2022 | 35750034 | PubTator, text mining | PubMed |
| The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia. | Cancers (Basel) | 2022 | 35740622 | PubTator, text mining | PubMed |
| 19th International Symposium on Epstein-Barr Virus and Associated Diseases, 29-30 July 2021, Asahikawa, Japan. | Cancers (Basel) | 2022 | 35740590 | PubTator, text mining | PubMed |
| Protein Farnesylation on Nasopharyngeal Carcinoma, Molecular Background and Its Potential as a Therapeutic Target. | Cancers (Basel) | 2022 | 35740492 | PubTator, text mining | PubMed |
| Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. | Clin Transl Oncol | 2022 | 35739348 | PubTator, text mining | PubMed |
| Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells. | Bioengineering (Basel) | 2022 | 35735488 | PubTator, text mining | PubMed |
| Identification and characterization of virus-encoded circular RNAs in host cells. | Microb Genom | 2022 | 35731570 | PubTator, text mining | PubMed |
| Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection. | Cell Commun Signal | 2022 | 35729616 | PubTator, text mining | PubMed |
| Interventions to improve water, sanitation, and hygiene for preventing soil-transmitted helminth infection. | Cochrane Database Syst Rev | 2022 | 35726112 | PubTator, text mining | PubMed |
| Role of exosomes in cellular communication between tumor cells and the tumor microenvironment. | Oncol Lett | 2022 | 35720493 | PubTator, text mining | PubMed |
| High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration. | J Immunol Res | 2022 | 35707002 | PubTator, text mining | PubMed |
| The Role of Exosomes in the Progression and Therapeutic Resistance of Hematological Malignancies. | Front Oncol | 2022 | 35692747 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies. | Cells | 2022 | 35681499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=30